Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cassandra Yun

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2020
Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Avidity Maturation and Association with Disease SeverityYiqi Ruben Luo, Indrani Chakraborty, Cassandra Yun, et al.
The Journal of Applied Laboratory Medicine|October 14, 2021
Rate of Serum SARS-CoV-2 Antibody Decline for Two mRNA VaccinesAlan H B Wu, Eric D Nguyen, Chui Mei Ong, et al.
Journal of Medical Microbiology|February 7, 2023
Detection of IgM, IgG, IgA and neutralizing antibody responses to SARS-CoV-2 infection and mRNA vaccinationCharles J Fleischmann, Christina A Bulman, Cassandra Yun, et al.
Clinical Chemistry|August 6, 2021
Diagnostic Value of Nucleocapsid Protein in Blood for SARS-CoV-2 InfectionYu Zhang, Chui Mei Ong, Cassandra Yun, et al.
Journal of Mass Spectrometry and Advances in the Clinical Lab|September 6, 2022
Development and application of a High-Resolution mass spectrometry method for the detection of fentanyl analogs in urine and serumYu Zhang, John C Halifax, Christina Tangsombatvisit, et al.
Journal of Analytical Toxicology|November 22, 2018
A Liquid-Chromatography High-Resolution Mass Spectrometry Method for Non-FDA Approved BenzodiazepinesXander M R van Wijk, Cassandra Yun, Shirin Hooshfar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2021
Differences in Post-mRNA Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G (IgG) Concentrations and Surrogate Virus Neutralization Test Response by Human Immunodeficiency Virus (HIV) Status and Type of Vaccine: A Matched Case-Control Observational StudyMatthew A Spinelli, Michael J Peluso, Kara L Lynch, et al.
The Lancet. HIV|May 2, 2021
SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational studyMatthew A Spinelli, Kara L Lynch, Cassandra Yun, et al.
Medrxiv : the Preprint Server for Health Sciences|February 3, 2021
Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19Jason Neidleman, Xiaoyu Luo, Ashley F George, et al.
Open Forum Infectious Diseases|August 16, 2021
Discordant Virus-Specific Antibody Levels, Antibody Neutralization Capacity, and T-cell Responses Following 3 Doses of SARS-CoV-2 Vaccination in a Patient With Connective Tissue DiseaseMichael J Peluso, Sadie E Munter, Kara L Lynch, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2020
Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Avidity Maturation and Association with Disease SeverityYiqi Ruben Luo, Indrani Chakraborty, Cassandra Yun, et al.
The Journal of Applied Laboratory Medicine|October 14, 2021
Rate of Serum SARS-CoV-2 Antibody Decline for Two mRNA VaccinesAlan H B Wu, Eric D Nguyen, Chui Mei Ong, et al.
Journal of Medical Microbiology|February 7, 2023
Detection of IgM, IgG, IgA and neutralizing antibody responses to SARS-CoV-2 infection and mRNA vaccinationCharles J Fleischmann, Christina A Bulman, Cassandra Yun, et al.
Clinical Chemistry|August 6, 2021
Diagnostic Value of Nucleocapsid Protein in Blood for SARS-CoV-2 InfectionYu Zhang, Chui Mei Ong, Cassandra Yun, et al.
Journal of Mass Spectrometry and Advances in the Clinical Lab|September 6, 2022
Development and application of a High-Resolution mass spectrometry method for the detection of fentanyl analogs in urine and serumYu Zhang, John C Halifax, Christina Tangsombatvisit, et al.
Journal of Analytical Toxicology|November 22, 2018
A Liquid-Chromatography High-Resolution Mass Spectrometry Method for Non-FDA Approved BenzodiazepinesXander M R van Wijk, Cassandra Yun, Shirin Hooshfar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2021
Differences in Post-mRNA Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G (IgG) Concentrations and Surrogate Virus Neutralization Test Response by Human Immunodeficiency Virus (HIV) Status and Type of Vaccine: A Matched Case-Control Observational StudyMatthew A Spinelli, Michael J Peluso, Kara L Lynch, et al.
The Lancet. HIV|May 2, 2021
SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational studyMatthew A Spinelli, Kara L Lynch, Cassandra Yun, et al.
Medrxiv : the Preprint Server for Health Sciences|February 3, 2021
Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19Jason Neidleman, Xiaoyu Luo, Ashley F George, et al.
Open Forum Infectious Diseases|August 16, 2021
Discordant Virus-Specific Antibody Levels, Antibody Neutralization Capacity, and T-cell Responses Following 3 Doses of SARS-CoV-2 Vaccination in a Patient With Connective Tissue DiseaseMichael J Peluso, Sadie E Munter, Kara L Lynch, et al.
Pageof 3